Anidrase carbónica
A anidrase carbônica é uma enzima que catalisa a conversão reversível de dióxido de carbono e água em bicarbonato e prótons. Esta enzima desempenha um papel crucial na manutenção do equilíbrio ácido-base, respiração e transporte de dióxido de carbono no sangue. Inibidores da anidrase carbônica são usados no tratamento de glaucoma, epilepsia e mal da altitude, bem como em pesquisas sobre homeostase ácido-base e troca gasosa. Na CymitQuimica, oferecemos uma gama de inibidores e reagentes de anidrase carbônica de alta qualidade para apoiar sua pesquisa em enzimologia, fisiologia respiratória e desenvolvimento terapêutico.
Foram encontrados 177 produtos de "Anidrase carbónica"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Benzthiazide
CAS:<p>Benzthiazide treats edema and hypertension by promoting diuresis and inhibiting kidney Na+/Cl- reuptake, but may reduce potassium and raise uric acid.</p>Fórmula:C15H14ClN3O4S3Pureza:99.34% - 99.79%Cor e Forma:Crystals From Acetone SolidPeso molecular:431.94Methazolamide
CAS:<p>Methazolamide (CL 8490) is a carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.</p>Fórmula:C5H8N4O3S2Pureza:99.31% - 99.77%Cor e Forma:Crystals From Water SolidPeso molecular:236.27Tioxolone
CAS:<p>Tioxolone is a metalloenzyme carbonic anhydrase I inhibitor.</p>Fórmula:C7H4O3SPureza:97.79%Cor e Forma:Light Yellow To Beige PowderPeso molecular:168.17Zonisamide
CAS:<p>Zonisamide (AD 810), a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures.</p>Fórmula:C8H8N2O3SPureza:99.05% - 99.9%Cor e Forma:Off-White PowderPeso molecular:212.23Topiramate
CAS:<p>Topiramate (RWJ 17021) is a unique antiseizure medication that is used in the treatment of partial and generalized seizures.</p>Fórmula:C12H21NO8SPureza:99.79% - 99.92%Cor e Forma:White To Off-White Crystalline PowderPeso molecular:339.36Methocarbamol
CAS:<p>Methocarbamol (AHR 85) is a centrally acting muscle relaxant whose mode of action has not been established.</p>Fórmula:C11H15NO5Pureza:99.96%Cor e Forma:Crystals From Benzene SolidPeso molecular:241.24pNNP
CAS:<p>pNNP is a substrate for PP2C assays and inhibits β-carbonic anhydrase, α-carbonate dehydrogenase, and H. pylori.</p>Fórmula:C6H6NO6PPureza:99.73%Cor e Forma:SolidPeso molecular:219.09Brinzolamide
CAS:<p>Brinzolamide (AL-4862) is a Carbonic Anhydrase Inhibitor. The mechanism of action of brinzolamide is as a Carbonic Anhydrase Inhibitor.</p>Fórmula:C12H21N3O5S3Pureza:99.84% - >99.99%Cor e Forma:Crystalline SolidPeso molecular:383.51Actarit
CAS:<p>Actarit (4-acetylaminophenylacetic acid) is an anti-inflammatory drug.</p>Fórmula:C10H11NO3Pureza:99.64% - 99.74%Cor e Forma:White Or Off-White Crystal Or Crystalline SolidPeso molecular:193.2Acipimox
CAS:<p>Acipimox (K-9321), a niacin derivative, treats hyperlipidemia in type 2 diabetics.</p>Fórmula:C6H6N2O3Pureza:98.98%Cor e Forma:Low Yellow Liquid Or CrystallinePeso molecular:154.12CA Ⅱ-IN-1
<p>CAⅡ-IN-1 (compound 2i) is an inhibitor of the CA Ⅱ isozyme, exhibiting an IC50 of 0.44 µM. This compound is utilized in metabolic research.</p>Fórmula:C18H19NO6SCor e Forma:SolidPeso molecular:377.41Carbonic anhydrase inhibitor 30
<p>Carbonic anhydrase inhibitor30 (compound 17) is an inhibitor of carbonic anhydrase with Ki values of 2.13 μM for hCA I and 0.161 μM for hCA II[1].</p>Fórmula:C23H22FN3O5SCor e Forma:SolidPeso molecular:471.12642CA IX/VEGFR-2-IN-3
<p>CAIX/VEGFR-2-IN-3 (Compound 6i) is an inhibitor of Carbonic Anhydrase IX and VEGFR-2, with IC50 values of 41 and 48 nM, respectively. It exhibits anticancer activity by inhibiting the growth of MCF-7 breast cancer cells (IC50 of 22.33 μM) and mouse fibroblast cell line 3T3, where cell viability is reduced to below 40% at a concentration of 100 μM. This compound is applicable for research in the field of cancer treatment.</p>Fórmula:C19H16ClN3O5S2Cor e Forma:SolidPeso molecular:465.93hCA/VEGFR-2-IN-3
<p>hCA/VEGFR-2-IN-3 (compound 8j) is an indolinonylbenzenesulfonamide with potential as a dual inhibitor of cancer-associated hCA IX/XII and VEGFR-2.</p>Fórmula:C24H28N6O6SPureza:98%Cor e Forma:SolidPeso molecular:528.58Phenylsulfamide
CAS:<p>Phenylsulfamide (Compound 10), acting as an inhibitor of human carbonic anhydrase-II (hCA-II), exhibits a dissociation constant (Kd) of 45.50 μM and an</p>Fórmula:C6H8N2O2SCor e Forma:SolidPeso molecular:172.2hCAIX-IN-19
<p>hCAIX-IN-19 is a sulfonamide inhibitor with an inhibition constant (KI) of 6.2 nM for hCAIX, exhibiting significant selectivity towards hCAIX over hCAI (hCA I/</p>Cor e Forma:Odour SolidCAIX/CAXII-IN-3
<p>CAIX/CAXII-IN-3 (compound 11) serves as an inhibitor for CAIX/CAXII, exhibiting an IC50 value of less than 65 nM. Additionally, this compound effectively inhibits the proliferation of human melanoma cells.</p>Cor e Forma:Odour SolidCAIX/CAXII-IN-4
<p>CAIX/CAXII-IN-4 (Compound 7h) is an inhibitor of carbonic anhydrase (CA) that binds to CAIX, CA XII, and CAII with Ki values of 1.324 μM, 0.435 μM, and 3.035 μM, respectively. This compound exhibits broad-spectrum anti-tumor activity and inhibits the proliferation of central nervous system tumor cells U251, with a GI50 of 0.361 μM.</p>Fórmula:C23H21N5O3SCor e Forma:SolidPeso molecular:447.51hCAII/IX-IN-1
<p>hCAII/IX-IN-1 (compound 4o) is a potent inhibitor of hCAII and hCAIX, with Ki values of 7.4 nM and 7.0 nM, respectively. It plays a significant role in cancer research.</p>Fórmula:C23H22N4O7S2Cor e Forma:SolidPeso molecular:530.573CA inhibitor 2
<p>Compound 4H is a potent carbonic anhydrase inhibitor with an IC50 value of 0.033 μM [1].</p>Fórmula:C7H9N7O3S3Pureza:98%Cor e Forma:SolidPeso molecular:335.392-Methoxy-4-propylphenol
CAS:<p>2-Methoxy-4-propylphenol is an inhibitor of human carbonic anhydrase isoenzymes 1/2/9/12 and has antifungal activity.</p>Fórmula:C10H14O2Cor e Forma:SolidPeso molecular:166.22hCA/VEGFR-2-IN-2
<p>Compound 8g (hCA/VEGFR-2-IN-2) is an indolinonylbenzenesulfonamide identified as a potential dual inhibitor targeting cancer-associated isozymes hCA IX/XII and</p>Fórmula:C23H26N6O5SPureza:98%Cor e Forma:SolidPeso molecular:498.55hCAII/XII-IN-1
<p>hCAII/XII-IN-1 (compound 4l) is a potent inhibitor of hCAXII and hCAII, with Ki values of 8.4 nM and 9.4 nM, respectively. It plays a significant role in cancer research.</p>Fórmula:C22H20N4O6S2Cor e Forma:SolidPeso molecular:500.547α-Pyrone
CAS:<p>Alpha-Pyrone exhibits inhibitory activity against tyrosinase, carbonic anhydrase 1, and carbonic anhydrase 9</p>Fórmula:C5H4O2Cor e Forma:SolidPeso molecular:96.08Carbonic anhydrase inhibitor 15
<p>Carbonic Anhydrase Inhibitor 15 (Compound 8), with an inhibitory constant (K_i) of 8.5 nM for hCA II, exhibits analgesic effects [1].</p>Fórmula:C27H33N5O2S2Pureza:98%Cor e Forma:SolidPeso molecular:523.71α-Glycosidase-IN-2
α-Glycosidase-IN-2 (compound 8b) is an inhibitor of α-glycosidase, displaying Ki values of 74.16 nM and 6.09 nM for aldose reductase and α-glycosidase, respectively. This compound is utilized in research related to diabetes.Fórmula:C25H22N6OS2Cor e Forma:SolidPeso molecular:486.61hCAI/II/IV-IN-28
CAS:<p>hCAI/II/IV-IN-28(WAY-638358) is a potent carbonic anhydrase inhibitor with potential anticonvulsant activity.</p>Fórmula:C14H15N3O3SPureza:96.48%Cor e Forma:SolidPeso molecular:305.35hCAXII-IN-7
<p>hCAXII-IN-7 (compound 6e) functions as an inhibitor of human carbonic anhydrase XII (hCA XII) and possesses blood-brain barrier (BBB) permeability.</p>Fórmula:C26H25N5O6S2Pureza:98%Cor e Forma:SolidPeso molecular:567.64hCAII-IN-7
<p>hCAII-IN-7 (R-13) inhibits human CA I, II, IV, IX with K i of 60.7, 320.7, 2298, 35.2 nM respectively.</p>Fórmula:C20H25N3O4SCor e Forma:SolidPeso molecular:403.5hCAIX/VII-IN-1
<p>hCAIX/VII-IN-1 is a selective inhibitor of human carbonic anhydrase isoforms VII and IX.</p>Fórmula:C16H13BFN3O3Pureza:98%Cor e Forma:SolidPeso molecular:325.1CAIX Inhibitor S4
CAS:<p>CAIX Inhibitor S4 (S4) is an effective inhibitor of carbonic anhydrase IX/XII with a Ki of 7 nM and 2 nM, respectively.</p>Fórmula:C15H17N3O4SPureza:99.07%Cor e Forma:SolidPeso molecular:335.38hCA/VEGFR-2-IN-1
<p>hCA/VEGFR-2-IN-1 (compound 13a) is a potent dual inhibitor targeting both Carbonic Anhydrase (CA) IX/XII and Vascular Endothelial Growth Factor Receptor 2 (</p>Fórmula:C21H17FN6O3SPureza:98%Cor e Forma:SolidPeso molecular:452.465,6-Dihydro-2H-pyran-2-one
CAS:<p>5,6-Dihydro-2H-pyran-2-one is a carbonic anhydrase 1/9 inhibitor that inhibits KB cell viability.</p>Fórmula:C5H6O2Cor e Forma:SolidPeso molecular:98.1hCAII-IN-6
<p>"hCAII-IN-6 (S-13) inhibits hCA II (4.4 nM) and isoforms I, IV, IX (9.2, 480.2, 14.7 nM). For glaucoma research."</p>Fórmula:C20H25N3O4SCor e Forma:SolidPeso molecular:403.5hCAIX/XII-IN-7
<p>Compound 3e (hCAIX/XII-IN-7) is a potent inhibitor of human carbonic anhydrase (hCA) isozymes IX and XII, displaying inhibitory constants (Kis) of 503.7 nM for</p>Fórmula:C17H14N6O3SPureza:98%Cor e Forma:SolidPeso molecular:382.4hCA/VEGFR-2-IN-4
<p>hCA/VEGFR-2-IN-4 (compound 15b), an indolinylbenzenesulfonamide, serves as a potential dual inhibitor targeting cancer-related human carbonic anhydrases hCA IX/</p>Fórmula:C22H23FN6O5SPureza:98%Cor e Forma:SolidPeso molecular:502.52Pyrocatechol
CAS:<p>Pyrocatechol, often known as catechol or benzene-1,2-diol, is a benzenediol, Pyrocatechol was produced at a large scale industrially, mainly as precursors to pesticides, flavors, and fragrances. Its sulfonic acid is often present in the urine of many mammals.</p>Fórmula:C6H6O2Cor e Forma:SolidPeso molecular:110.11TSPO/Carbonic Anhydrase Modulator 1
<p>TSPO/Carbonic Anhydrase Modulator 1 (Compound 3) acts as a dual modulator of mitochondrial translocator protein and carbonic anhydrase, with a TSPOKi of 1.340 μM and a CAVII KA of 10.7 μM. It enhances neurosteroid production, increases BDNF gene expression, and demonstrates neuroprotective activity.</p>Fórmula:C35H51N3O3Cor e Forma:SolidPeso molecular:561.798hCAIX/XII-IN-14
<p>hCAIX/XII-IN-14 (Compound 1i) is an inhibitor of hCAIX and hCAXII, with Ki values of 9.4 nM for hCAII, 5.6 nM for hCAIX, and 6.3 nM for hCAXII.</p>Fórmula:C16H14F3N3O4SCor e Forma:SolidPeso molecular:401.36Dorzolamide
CAS:<p>Dorzolamide is an anti-glaucoma agent and is a carbonic anhydrase inhibitor.</p>Fórmula:C10H16N2O4S3Pureza:98%Cor e Forma:White Or Almost White Crystalline PowderPeso molecular:324.44Carbonic anhydrase inhibitor 32
<p>Carbonic anhydrase inhibitor32 (compound 5B) is an orally active, selective inhibitor of hCA (carbonic anhydrase) II/VII, with Ki values of 6.3 nM for hCA II, 10.1 nM for hCA VII, and 681 nM for hCA I. It shows potential for neuroprotection and anticonvulsant effects by reducing mTOR activation and increasing hippocampal KCC2 levels.</p>Fórmula:C17H16N6O3SCor e Forma:SolidPeso molecular:384.41(E)-Dehydrodiconiferyl alcohol
CAS:<p>(E)-Dehydrodiconiferyl alcohol inhibits hCA IX/XII enzymes and blocks NF-κB nuclear translocation in healing tissues.</p>Fórmula:C20H22O6Cor e Forma:SolidPeso molecular:358.39Carbonic anhydrase inhibitor 31
<p>Carbonic anhydrase inhibitor31 is an mtCA2 inhibitor (Ki: 5.2 nM) that can be used in antituberculosis research.</p>Fórmula:C24H20N6O5SCor e Forma:SolidPeso molecular:504.12159hCAIX-IN-17
<p>hCA IX-IN-1 inhibits hCA I/II/IX/XII with Ki of 331.4/28.4/9.4/17.8 nM, has anticancer properties.</p>Fórmula:C19H18N2O3SCor e Forma:SolidPeso molecular:354.42VM4-037
CAS:<p>VM4-037 is a PET imaging agent used for carbonic anhydrase IX.</p>Fórmula:C26H29FN6O7S2Cor e Forma:SolidPeso molecular:620.67hCA/Wnt/β-catenin-IN-1
<p>hCA/Wnt/β-catenin-IN-1 (Compd 15) serves as an inhibitor with selective affinity for hCA isoforms II, IX, and XII, exhibiting K i values of 33.6, 24.1, and 6.8</p>Cor e Forma:Odour SolidCarbonic anhydrase inhibitor 29
<p>Carbonic anhydrase inhibitor29 (Compound 5d) is an inhibitor targeting carbonic anhydrase IX and XII, with an inhibition constant (Ki) of 26.6 nM for carbonic anhydrase IX and a Ki of 10.9 nM for carbonic anhydrase XII. Carbonic anhydrase inhibitor29 can be used in cancer research.</p>Cor e Forma:Odour SolidCAXII-IN-2
<p>CAXII-IN-2 (compound 3j) is a highly effective inhibitor of CAXII. It demonstrates inhibitory activity against CA IX and CAXII, with Ki values of 27.4 nM and 4.0 nM, respectively.</p>Fórmula:C16H13FNO4PCor e Forma:SolidPeso molecular:333.05662hCAII-IN-8
CAS:<p>Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.</p>Fórmula:C15H16N2O5SPureza:99.73%Cor e Forma:SoildPeso molecular:336.36hCAI/II-IN-10
<p>hCAI/II-IN-10 (Compound 5d) is an inhibitor of human carbonic anhydrase I and II (hCA I and hCA II), with IC50 values of 4.32 nM and 3.89 nM, respectively.</p>Fórmula:C24H17Cl2N3O3S2Cor e Forma:SolidPeso molecular:530.446DPP IV/hCA II-IN-1
CAS:<p>DPP IV/hCA II-IN-1: strong DPP IV & CA inhibitor, IC50=0.049μM (DPP IV), Ki=0.0361-3.034μM (CA II-IV).</p>Fórmula:C17H20N2O5SCor e Forma:SolidPeso molecular:364.42Bendroflumethiazide
CAS:<p>Bendroflumethiazide (Naturetin) is a thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)</p>Fórmula:C15H14F3N3O4S2Pureza:98% - >99.99%Cor e Forma:Crystals From Dioxane SolidPeso molecular:421.41Carbonic anhydrase
CAS:<p>Carbonic anhydrase, a zinc enzyme in all life forms, converts CO2 to bicarbonate; studied for cancer, glaucoma, obesity, epilepsy.</p>Cor e Forma:SolidCarbonic anhydrase inhibitor 26
<p>Compound 6T, designated as Carbonic anhydrase inhibitor26, acts as an inhibitor of Carbonic Anhydrase II (Carbonic AnhydraseII), exhibiting an IC50 value of 9.10 ± 0.26 μM.</p>Fórmula:C17H14N6O4Cor e Forma:SolidPeso molecular:366.33AV22-149
<p>AV22-149 (compound 22) is an inhibitor of Carbonic Anhydrase .</p>Fórmula:C23H28F3N3O6S2Cor e Forma:SolidPeso molecular:563.61DOTA-XYIMSR-01
CAS:<p>DOTA-XYIMSR-01 is a molecular probe targeting CAIX, capable of being labeled with 177Lu for the treatment and localization of malignant gliomas. The uptake of [177Lu]Lu-XYIMSR-01 in U87MG tumors is 6.19% injected dose per gram (% ID/g), with a tumor-to-muscle uptake ratio of 20.14. In an orthotopic glioma model, co-administration with temozolomide significantly enhances survival rates and inhibits tumor growth in mice. DOTA-XYIMSR-01 shows potential for research in the field of cancer treatment.</p>Fórmula:C61H88N16O22S2Cor e Forma:SolidPeso molecular:1461.57Acesulfame
CAS:<p>Acesulfame inhibits CA9/12 and can be used to study inflammation-related diseases.</p>Fórmula:C4H5NO4SCor e Forma:SolidPeso molecular:163.15Carbonic anhydrase inhibitor 18
<p>Carbonic anhydrase inhibitor18 (Compound 9) is an inhibitor of human carbonic anhydrase (hCA) isozymes, with Ki values of 604.8 nM for hCA I, 333.6 nM for hCA II, 1.9 nM for hCA IX, and 6.7 nM for hCA XII. Carbonic anhydrase inhibitor18 is applicable in cancer research.</p>Fórmula:C26H28N4O6S2Peso molecular:556.14503Girentuximab
CAS:<p>Girentuximab (G250) is an anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anti-cancer activity for the study of uroepithelial carcinoma PET (ZiPUP).</p>Cor e Forma:LiquidPeso molecular:145.55 kDahCAIX/XII-IN-11
<p>hCAIX/XII-IN-11 (Compound 6c) is an inhibitor of hCA IX and hCA XII, exhibiting Ki values of 0.7 μM for both isoforms. This compound is applicable in cancer research.</p>Fórmula:C13H10FN3O4Peso molecular:291.06553GZ22-4
<p>GZ22-4 is a near-infrared (NIR) fluorescent probe with a high affinity for carbonic anhydrase IX (CAIX), exhibiting a dissociation constant (Kd) of 0.2 nM. It is applicable in studies for visualizing CAIX-positive tumors.</p>Fórmula:C88H126F3N6NaO24S4Peso molecular:1858.75561SH7s
<p>SH7s is an effective carbonic anhydrase inhibitor, exhibiting Ki values of 15.9 nM for hCA IX and 55.2 nM for hCA XII. Additionally, SH7s acts as a hypoxia-mediated chemosensitizer in colorectal cancer cells.</p>Fórmula:C24H19ClF3N5O4SCor e Forma:SolidPeso molecular:565.95hCA XII-IN-6
<p>Compound 4d, known as hCA XII-IN-6, is a potent inhibitor of human carbonic anhydrase XII (hCA XII) with a Ki value of 84.2 nM and exhibits anti-proliferative</p>Fórmula:C11H9N5O3S2Pureza:98%Cor e Forma:SolidPeso molecular:323.35Chlorothiazide
CAS:<p>Chlorothiazide (Diuril) is a thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE.</p>Fórmula:C7H6ClN3O4S2Pureza:98.46% - 98.91%Cor e Forma:Crystals Physical Description Crystals; White Powder (Ntp 1992)Peso molecular:295.72Carbonic Anhydrase 12 Protein, Cynomolgus, Recombinant (His)
<p>Carbonic anhydrases (CAs) are a family of enzymes involved in the pH regulation of metabolically active cells/tissues.</p>Cor e Forma:Lyophilized PowderPeso molecular:32.04 kDa (predicted). Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result.Acetazolamide-d3
CAS:<p>Acetazolamide D3 is a deuterium-labeled Acetazolamide. Acetazolamide is a potent carbonic anhydrase inhibitor.</p>Fórmula:C4H6N4O3S2Pureza:98%Cor e Forma:SolidPeso molecular:225.26M 12325
CAS:<p>M 12325 is used in the production of furosemide; rhinitis and occupational asthma were observed in workers from a lasamide production line.</p>Fórmula:C7H5Cl2NO4SCor e Forma:White To Almost White Solid PowderPeso molecular:270.09Brinzolamide hydrochloride
<p>Brinzolamide (AL-4862) HCl selectively inhibits carbonic anhydrase II, reducing IOP for glaucoma research. IC50: 3.2 nM.</p>Cor e Forma:Solid4-(benzyloxy)benzene-1-sulfonamide
CAS:<p>4-(benzyloxy)benzene-1-sulfonamide is inhibitor of human recombinant CA-7.</p>Fórmula:C13H13NO3SPureza:97.54%Cor e Forma:SolidPeso molecular:263.31Zolamide
CAS:<p>Zolamide (CL 5343) may be used to prevent altitude sickness and reduce the symptoms.</p>Fórmula:C2H4N4O2S2Pureza:99.75%Cor e Forma:SolidPeso molecular:180.21EMAC10101d
CAS:<p>compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with an</p>Fórmula:C17H15Cl2N3O2S2Pureza:99.96%Cor e Forma:SolidPeso molecular:428.36Benzenesulfonamide
CAS:<p>Benzenesulfonamide (Benzosulfonamide) ia an inhibitor of carbonic anhydrases.</p>Fórmula:C6H7NO2SPureza:99.42% - 99.99%Cor e Forma:White Crystalline PowderPeso molecular:157.19Dichlorphenamide
CAS:<p>Dichlorphenamide (Diclofenamide) is a carbonic anhydrase inhibitor that is used in the treatment of glaucoma.</p>Fórmula:C6H6Cl2N2O4S2Pureza:96.87% - 97.25%Cor e Forma:Needles From Dimethylsulfoxide + Water SolidPeso molecular:305.16Benzolamide
CAS:<p>Benzolamide (CL 11366) inhibits carbonic anhydrase effectively and low-threshold calcium currents in hippocampal pyramidal neurons.</p>Fórmula:C8H8N4O4S3Pureza:99.31%Cor e Forma:SolidPeso molecular:320.37Dichlorphenamide disodium
CAS:<p>Dichlorphenamide disodium: an oral carbonic anhydrase inhibitor that lowers eye pressure, promising for glaucoma study.</p>Fórmula:C6H6Cl2N2Na2O4S2Cor e Forma:SolidPeso molecular:351.12Dimethylfraxetin
CAS:<p>Dimethylfraxetin (6,7,8-Trimethoxycoumarin) is a Carbonic anhydrase inhibitor(Ki：0.0097 μM)</p>Fórmula:C12H12O5Pureza:99.96% - ≥95%Cor e Forma:SolidPeso molecular:236.224-Amino-6-(trifluoromethyl)benzene-1,3-disulfonamide
CAS:<p>4-Amino-6-(trifluoromethyl)benzene-1,3-disulfonamide (4-Amino-6-(trifluoromethyl)benzene-1,3-d) is a carbonic anhydrase inhibitor, used as a potential anti-</p>Fórmula:C7H8F3N3O4S2Pureza:98.58%Cor e Forma:SolidPeso molecular:319.28Dorzolamide hydrochloride
CAS:<p>Dorzolamide hydrochloride (MK507 hydrochloride) is the hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that</p>Fórmula:C10H17ClN2O4S3Pureza:99.48% - 99.67%Cor e Forma:White Off-White Crystalline PowderPeso molecular:360.9Methyclothiazide
CAS:<p>Methyclothiazide (Aquatensen) is a substituted benzothiadiazide, used to treat high blood pressure and fluid retention caused by various conditions including</p>Fórmula:C9H11Cl2N3O4S2Pureza:99.13%Cor e Forma:SolidPeso molecular:360.242,3-dihydro-1H-indene-5-sulfonamide
CAS:<p>2,3-dihydro-1H-indene-5-sulfonamide is Carbonic anhydrase 12 (human) inhibitor.</p>Fórmula:C9H11NO2SPureza:99.89%Cor e Forma:SolidPeso molecular:197.25Orthanilamide
CAS:<p>Orthanilamide (Orthanilamide) is a molecule containing the sulfonamide functional group attached to an aniline.</p>Fórmula:C6H8N2O2SPureza:99.72% - 99.96%Cor e Forma:White To Pale Cream Crystalline Powder Or CrystalsPeso molecular:172.2Indisulam
CAS:<p>Indisulam (E 7070) is a dual-action anticancer drug, blocking G1/S cell cycle transition by degrading cyclin E and activating p53/p21.</p>Fórmula:C14H12ClN3O4S2Pureza:98.68% - 99.77%Cor e Forma:SolidPeso molecular:385.85U-104
CAS:<p>U-104 (NSC-213841) is an effective carbonic anhydrase (CA) inhibitor for CA IX( Ki=45.1 nM) and CA XII(Ki=4.5 nM).</p>Fórmula:C13H12FN3O3SPureza:98.76% - 99.88%Cor e Forma:SolidPeso molecular:309.32Ethoxzolamide
CAS:<p>Ethoxzolamide (L-643786) is a carbonic anhydrase inhibitor.</p>Fórmula:C9H10N2O3S2Pureza:98.27% - 99.62%Cor e Forma:Crystals From Ethyl Acetate + Skellysolve B SolidPeso molecular:258.32Polmacoxib
CAS:<p>Polmacoxib, a first-class NSAID, dual inhibitor of CA and COX-2, may hinder colorectal cancer growth in mice.</p>Fórmula:C18H16FNO4SPureza:97.88%Cor e Forma:SolidPeso molecular:361.39Fluorometholone Acetate
CAS:<p>Fluorometholone Acetate (Oxylone acetate) is a synthetic corticosteroid, used in the treatment of steroid responsive inflammatory conditions of the eye.</p>Fórmula:C24H31FO5Pureza:99.76%Cor e Forma:SolidPeso molecular:418.50GV2-20
CAS:<p>GV2-20 is an effective carbonic anhydrase 2 inhibitors.</p>Fórmula:C15H13N3O6Pureza:98%Cor e Forma:SolidPeso molecular:331.28Disulfamide
CAS:<p>Disulfamide: Oral carbonic anhydrase inhibitor, IC50 0.07 μM, diuretic by blocking Na+/HCO3- reabsorption.</p>Fórmula:C7H9ClN2O4S2Pureza:98.1%Cor e Forma:SolidPeso molecular:284.74HCAIX-IN-2
CAS:<p>HCAIX-IN-2 (compound 9d) is a selective inhibitor of carbonic anhydrase and acts on hCA IX (Ki: 24.6 nM) and hCA XII (Ki: 45.3 nM).</p>Fórmula:C19H16N8O4SCor e Forma:SolidPeso molecular:452.45hCAIX-IN-11
CAS:<p>hCAIX-IN-11 inhibits carbonic anhydrases IX & XII with Ki of 32.7 nM & 623.5 nM, respectively.</p>Fórmula:C21H15ClN4O3Cor e Forma:SolidPeso molecular:406.82hCAI/II-IN-1
CAS:<p>hCAI/II-IN-1 (Compound 3h) is a human carbonic anhydrase I and II (hCA I/II) inhibitor that acts on hCA I (IC50: 0.047 μM) and hCA II (IC50: 0.024 μM).</p>Fórmula:C18H29N5O3S3Cor e Forma:SolidPeso molecular:459.65hCAIX/XII-IN-2
CAS:<p>Compound 6a: Selective hCAIX/XII inhibitor; Ki: 30 nM (hCAIX), 3.6 nM (hCAXII); >10,000 nM (hCAI/II).</p>Fórmula:C19H14N2O4Cor e Forma:SolidPeso molecular:334.33CDK2-IN-12
CAS:<p>CDK2-IN-12 (10b), potent CDK2 inhibitor, IC50: 11.6 μM; inhibits hCA I/II/IX/XII, KI: 3534/638.4/44.3/48.8 nM; anti-cancer properties.</p>Fórmula:C20H17N9O2SCor e Forma:SolidPeso molecular:447.47Clofenamide
CAS:<p>Clofenamide is a low-ceiling sulfonamide diuretic.</p>Fórmula:C6H7ClN2O4S2Cor e Forma:SolidPeso molecular:270.71hCAII-IN-2
CAS:<p>hCAII-IN-2 inhibits human carbonic anhydrases I, II, IX, XII with Ki values of 261.4, 3.8, 19.6, 45.2 nM respectively.</p>Fórmula:C25H18ClN5O4SCor e Forma:SolidPeso molecular:519.96hCAIX/XII-IN-3
CAS:<p>Compound 6q inhibits hCAIX/CAXII; K i : hCAI >10000 nM, hCAII >10000 nM, hCAIX 66.2 nM, hCAXII 4.4 nM.</p>Fórmula:C20H13F3N2O4Cor e Forma:SolidPeso molecular:402.32CDK2-IN-11
CAS:<p>CDK2-IN-11 inhibits CDK2 (IC50: 6.4 μM) and targets hCA II, IX, XII (Ki: 23.4-56.3 nM); suited for cancer research.</p>Fórmula:C18H14ClN7O2SCor e Forma:SolidPeso molecular:427.87hCA I-IN-1
CAS:<p>hCA I-IN-1 inhibits hCA I (Ki: 38.3 nM), II (Ki: 716.4 nM), IX (Ki: 940.1 nM), XII (Ki: 192.8 nM).</p>Fórmula:C27H23N5O4SCor e Forma:SolidPeso molecular:513.57hCAXII-IN-3
CAS:<p>hCAXII-IN-3 (Compound 6o) is a selective inhibitor of human carbonic anhydrase XII (hCAXII) (Ki: 10.0 nM).</p>Fórmula:C26H20BrN5O3SCor e Forma:SolidPeso molecular:562.44Carbonic anhydrase inhibitor 14
CAS:<p>CA inhibitor 14 blocks hCA I/II/IX/XII (K i of 1203/99.7/9.4/27.7 nM) and CDK2 (IC50: 20.3 μM), showing antitumor effects.</p>Fórmula:C18H17N7O2SCor e Forma:SolidPeso molecular:395.44
